Get the Stockscreener App
92.89
1.29%
1.18
After Hours:
92.89
Lemaitre Vascular Inc stock is traded at $92.89, with a volume of 133.90K.
It is up +1.29% in the last 24 hours and up +2.88% over the past month.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.
See More
Previous Close:
$91.71
Open:
$91.84
24h Volume:
133.90K
Relative Volume:
1.04
Market Cap:
$2.05B
Revenue:
$205.62M
Net Income/Loss:
$37.68M
P/E Ratio:
76.77
EPS:
1.21
Net Cash Flow:
$31.69M
1W Performance:
+1.62%
1M Performance:
+2.88%
6M Performance:
+39.98%
1Y Performance:
+70.50%
1-Day Range:
$90.98
$93.24
1-Week Range:
$87.20
$93.24
52-Week Range:
$44.27
$93.24
Lemaitre Vascular Inc Stock (LMAT) Company Profile
Name
Lemaitre Vascular Inc
Sector
Industry
Phone
781-221-2266
Address
63 SECOND AVENUE, BURLINGTON, MA
Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-06-24 | Resumed | KeyBanc Capital Markets | Sector Weight |
| Oct-23-23 | Initiated | JMP Securities | Mkt Outperform |
| Sep-06-23 | Initiated | Oppenheimer | Outperform |
| Aug-03-23 | Downgrade | Jefferies | Buy → Hold |
| May-03-23 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Oct-28-22 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Sep-16-21 | Initiated | Jefferies | Buy |
| Feb-12-21 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Mar-16-20 | Upgrade | Sidoti | Neutral → Buy |
| Oct-24-19 | Downgrade | First Analysis Sec | Strong Buy → Outperform |
| Oct-24-19 | Upgrade | Lake Street | Hold → Buy |
| Oct-14-19 | Upgrade | First Analysis Sec | Outperform → Strong Buy |
| Jul-25-19 | Reiterated | Barrington Research | Outperform |
| Jul-25-19 | Upgrade | First Analysis Sec | Neutral → Outperform |
| Oct-08-18 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Oct-08-18 | Upgrade | ROTH Capital | Neutral → Buy |
| Jun-08-18 | Resumed | ROTH Capital | Buy |
| Apr-26-18 | Downgrade | Stifel | Buy → Hold |
| Apr-26-18 | Upgrade | The Benchmark Company | Hold → Buy |
| Oct-27-17 | Downgrade | First Analysis Sec | Overweight → Equal-Weight |
| Oct-27-17 | Downgrade | The Benchmark Company | Buy → Hold |
| Jul-10-17 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jul-10-17 | Downgrade | The Benchmark Company | Buy → Hold |
| Mar-21-17 | Initiated | First Analysis Sec | Overweight |
| Feb-22-17 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Sep-22-16 | Downgrade | Sidoti | Buy → Neutral |
| Jul-28-16 | Reiterated | Barrington Research | Outperform |
| Feb-25-16 | Reiterated | Barrington Research | Outperform |
View All
Lemaitre Vascular Inc Stock (LMAT) Latest News
LeMaitre Vascular's SWOT analysis: niche market dominance fuels stock growth - Investing.com UK
LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Stock Is Going Strong: Is the Market Following Fundamentals? - Yahoo Finance
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Sold by Dimensional Fund Advisors LP - MarketBeat
Alpha DNA Investment Management LLC Buys New Shares in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World
ProShare Advisors LLC Sells 17,708 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
Envestnet Asset Management Inc. Acquires 1,520 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World
All You Need to Know About LeMaitre (LMAT) Rating Upgrade to Strong Buy - Yahoo Finance
2024the success of the application in Bouches-du-Rhône - Actual News Magazine
Veeam acquires SaaS backup outfit Alcion - Blocks & Files
Professor Luo Min Appointed as Chairman of Spine Neurocardiology Interdisciplinary Professional Committee in China to Promote Development of Innovative Heart Disease Treatments - Morningstar
News | Is Valérie Létard's appointment a positive signal for housing? - CoStar Group
Video: French duo Tomas Lemoine and Edgar Briole go big at Les 2 Alpes - off.road.cc
Acadian Asset Management LLC Buys Shares of 1,272 LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World
(LMAT) Investment Analysis and Advice - Stock Traders Daily
LeMaitre Vascular (NASDAQ:LMAT) Rating Reiterated by Barrington Research - Defense World
LeMaitre Vascular (NASDAQ:LMAT) Rating Reiterated by Barrington Research - MarketBeat
Veeam acquires data management and protection startup Alcion - CRN Australia
L'Occitane: Departure of CEO Laurent Marteau - Fashion Network
Veeam acquires Microsoft 365 data protection startup Alcion - SiliconANGLE News
Commonwealth Equity Services LLC Reduces Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World
Investors Met With Slowing Returns on Capital At LeMaitre Vascular (NASDAQ:LMAT) - Simply Wall St
Bioprosthetics Market to Observe Significant Growth 2024-2033 - Cauverynews
Victory Capital Management Inc. Sells 31,839 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
United States Synthetic Vascular Grafts Market By Application - Third Eye News
LeMaitre Vascular (LMAT) Surged Due to Robust Global Markets - Insider Monkey
LeMaitre Vascular (LMAT) Surged Due to Robust Global Markets - Yahoo Finance
Is There Now An Opportunity In LeMaitre Vascular, Inc. (NASDAQ:LMAT)? - Yahoo Finance
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Given Average Recommendation of "Buy" by Analysts - MarketBeat
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Average Rating of “Buy” from Analysts - Defense World
Johnson Investment Counsel Inc. Has $2.52 Million Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
Nicholas Investment Partners LP Purchases New Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
Rice Hall James & Associates LLC Has $18.59 Million Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
Clot Management Devices Market See Incredible Growth 2024-2031 - openPR
Here's Why Universal Health Shares are Attracting Investors Now - TradingView
Regional Insights: Vascular Patches Market Size 2024-2031 - openPR
Summit Creek Advisors LLC Has $17.69 Million Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Purchased by Allspring Global Investments Holdings LLC - Defense World
Mesirow Institutional Investment Management Inc. Sells 136,470 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
When (LMAT) Moves Investors should Listen - Stock Traders Daily
Jackson Creek Investment Advisors LLC Buys Shares of 14,078 LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Price In Tune With Earnings - Simply Wall St
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Sold by Raymond James & Associates - Defense World
Maryland State Retirement & Pension System Has $573,000 Stock Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World
The Attractiveness of Investing In Lemaitre Vascular Inc (LMAT) is Growing - Knox Daily
Vascular Patches Market to Witness Huge Growth by 2031Terumo Corporation & LeMaitre Vascular, Inc - openPR
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Short Interest Up 30.8% in August - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) shareholders have earned a 25% CAGR over the last five years - Yahoo Finance
90,458 Shares in LeMaitre Vascular, Inc. (NASDAQ:LMAT) Bought by F M Investments LLC - MarketBeat
Louisiana State Employees Retirement System Raises Stock Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World
LeMaitre Vascular (NASDAQ:LMAT) Downgraded to Hold at StockNews.com - Defense World
StockNews.com Lowers LeMaitre Vascular (NASDAQ:LMAT) to Hold - MarketBeat
Lemaitre Vascular Inc Stock (LMAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.15%
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):